Literature DB >> 1869838

Streptokinases produced by pathogenic group C streptococci demonstrate species-specific plasminogen activation.

H E McCoy1, C C Broder, R Lottenberg.   

Abstract

The species specificities of plasminogen activation and binding of plasmin by pathogenic group C streptococci isolated from humans, horses, and pigs were examined. Of 56 streptococcal isolates, 52 elaborated plasminogen activator activity and 49 of these had specificity for plasminogen of the homologous host. Analysis of supernatants from 13 isolates indicated that the plasminogen activator activity resulted from secreted streptokinases. These 13 streptokinases were antigenically related and bound all three plasminogens, indicating that the binding recognition sites were conserved despite the observed species-specific activation. In addition, all group C isolates tested demonstrated surface receptors that bound human, equine, and porcine plasmin. Species-specific plasminogen activation may be an early step in events resulting in infection and may account for the species preference of certain streptococci.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1869838     DOI: 10.1093/infdis/164.3.515

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  21 in total

1.  The activation of bovine plasminogen by PauA is not required for virulence of Streptococcus uberis.

Authors:  Philip N Ward; Terence R Field; Christopher D Rapier; James A Leigh
Journal:  Infect Immun       Date:  2003-12       Impact factor: 3.441

2.  Coevolutionary patterns in plasminogen activation.

Authors:  Inna P Gladysheva; Ryan B Turner; Irina Y Sazonova; Lin Liu; Guy L Reed
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-23       Impact factor: 11.205

3.  Cell surface antigens of Mycoplasma species bovine group 7 bind to and activate plasminogen.

Authors:  Kylie Bower; Steven P Djordjevic; Nicholas M Andronicos; Marie Ranson
Journal:  Infect Immun       Date:  2003-08       Impact factor: 3.441

4.  Cloning, sequence analysis, and expression in Escherichia coli of a streptococcal plasmin receptor.

Authors:  R Lottenberg; C C Broder; M D Boyle; S J Kain; B L Schroeder; R Curtiss
Journal:  J Bacteriol       Date:  1992-08       Impact factor: 3.490

Review 5.  Streptokinase--the drug of choice for thrombolytic therapy.

Authors:  Adinarayana Kunamneni; Thaer Taleb Abed Abdelghani; Poluri Ellaiah
Journal:  J Thromb Thrombolysis       Date:  2007-02       Impact factor: 2.300

Review 6.  Fibrinogen Is at the Interface of Host Defense and Pathogen Virulence in Staphylococcus aureus Infection.

Authors:  Ya-Ping Ko; Matthew J Flick
Journal:  Semin Thromb Hemost       Date:  2016-04-07       Impact factor: 4.180

7.  Characterization of PauB, a novel broad-spectrum plasminogen activator from Streptococcus uberis.

Authors:  Philip N Ward; James A Leigh
Journal:  J Bacteriol       Date:  2002-01       Impact factor: 3.490

8.  Species specificity of plasminogen activation and acquisition of surface-associated proteolytic activity by group C streptococci grown in plasma.

Authors:  B Schroeder; M D Boyle; B R Sheerin; A C Asbury; R Lottenberg
Journal:  Infect Immun       Date:  1999-12       Impact factor: 3.441

9.  Reduced thrombin generation increases host susceptibility to group A streptococcal infection.

Authors:  Hongmin Sun; Xixi Wang; Jay L Degen; David Ginsburg
Journal:  Blood       Date:  2008-12-03       Impact factor: 22.113

10.  Immunogenic and plasminogen-binding surface-associated alpha-enolase of Trichomonas vaginalis.

Authors:  V Mundodi; A S Kucknoor; J F Alderete
Journal:  Infect Immun       Date:  2007-12-10       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.